Celcuity Inc

General ticker "CELC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $544.8M

Celcuity Inc does not follow the US Stock Market performance with the rate: -0.3%.

Estimated limits based on current volatility of 3.1%: low 11.76$, high 12.52$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [10.03$, 21.14$]
  • 2024-12-30 to 2025-12-30 estimated range: [10.41$, 21.46$]

Financial Metrics affecting the CELC estimates:

  • Negative: Non-GAAP EPS, $ of -2.69 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -13.40 <= 2.35
  • Negative: negative Net income
  • Positive: -0.96 < Investing cash flow per share, $ of -0.21
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term CELC quotes

Long-term CELC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $28.36MM $39.39MM $66.23MM
Operating Income $-28.36MM $-39.39MM $-66.23MM
Non-Operating Income $-1.25MM $-0.98MM $2.45MM
Interest Expense $1.26MM $2.11MM $0.00MM
R&D Expense $25.76MM $35.29MM $60.59MM
Income(Loss) $-29.61MM $-40.37MM $-63.78MM
Profit(Loss) $-29.61MM $-40.37MM $-63.78MM
Stockholders Equity $68.71MM $133.77MM $139.77MM
Inventory $0.30MM $0.20MM $0.00MM
Assets $85.91MM $175.70MM $191.22MM
Operating Cash Flow $-20.31MM $-36.01MM $-53.81MM
Capital expenditure $0.08MM $0.16MM $0.10MM
Investing Cash Flow $-0.08MM $-144.03MM $-5.01MM
Financing Cash Flow $93.04MM $120.33MM $64.91MM
Earnings Per Share* $-2.28 $-2.68 $-2.69

* EPS are Split Adjusted, recent splits may be reflected with a delay.